Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Inlyta“
Suchtreffer
Begriffe & Kennungen
Inlyta · 4.8 · 10 All System organ Frequency a Grade 3b Grade 4b Adverse reactions Gradesb class category % % % Aspartate 6.1
Eintrag öffnenInlyta · 4.8 · 11 Thyroid dysfunction (see section 4.4) In a controlled clinical study with axitinib for the treatment of pat
Eintrag öffnenInlyta · 4.8 · 12 gingival bleeding (1.1%), gastric haemorrhage (0.6%), cerebral haemorrhage (0.3%) and lower gastrointestina
Eintrag öffnenInlyta · 4.8 · 8 gastrointestinal perforation and fistula formation, wound healing complications, PRES, proteinuria, and elev
Eintrag öffnenInlyta · 4.8 · 9 All System organ Frequency a Grade 3b Grade 4b Adverse reactions Gradesb class category % % % Vascular disor
Eintrag öffnenInlyta · 4.8 · Arterial embolic and thrombotic events (see section 4.4) In a controlled clinical study with axitinib for the
Eintrag öffnenInlyta · 4.8 · Cardiac failure events (see section 4.4) In a controlled clinical study with axitinib (N = 359) for the treatm
Eintrag öffnenInlyta · 4.8 · Categories have been assigned based on absolute frequencies in the pooled clinical studies data. Within each s
Eintrag öffnenInlyta · 4.8 · Description of selected adverse reactions
Eintrag öffnenInlyta · 4.8 · Gastrointestinal perforation and fistula formation (see section 4.4) In a controlled clinical study with axiti
Eintrag öffnenInlyta · 4.8 · Haemorrhage (see section 4.4) In a controlled clinical study with axitinib for the treatment of patients with
Eintrag öffnenInlyta · 4.8 · In monotherapy studies with axitinib (N = 672) for the treatment of patients with RCC, cardiac failure events
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, arterial embolic an
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, gastrointestinal pe
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, haemorrhagic events
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, hypothyroidism was
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, polycythaemia was r
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, venous embolic and
Eintrag öffnenInlyta · 4.8 · Polycythaemia (see Elevation of haemoglobin or haematocrit in section 4.4) In a controlled clinical study with
Eintrag öffnenInlyta · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen